Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 4th edition, 372 pages

+ the daily Top 10


  Malignant Melanoma

  Free Subscription


17.08.2020

2 Ann Surg Oncol
1 Br J Dermatol
1 Cancer
1 Cancer Lett
1 Int J Cancer
7 J Am Acad Dermatol
1 J Immunol
1 J Invest Dermatol
2 J Surg Oncol
1 Melanoma Res
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Surg Oncol

  1. SINNAMON AJ, Gimotty PA, Karakousis GC, Yang YX, et al
    Survival Outcomes Following Lymph Node Biopsy in Thin Melanoma-A Propensity-Matched Analysis.
    Ann Surg Oncol. 2020 Aug 10. pii: 10.1245/s10434-020-08997.
    PubMed         Abstract available

  2. FONSECA IB, Lindote MVN, Monteiro MR, Doria Filho E, et al
    Sentinel Node Status is the Most Important Prognostic Information for Clinical Stage IIB and IIC Melanoma Patients.
    Ann Surg Oncol. 2020 Aug 7. pii: 10.1245/s10434-020-08959.
    PubMed         Abstract available


    Br J Dermatol

  3. KIM HS, Ahn HS
    Response to 'The incidence and survival of melanoma and nonmelanoma skin cancer in patients with vitiligo: a nationwide population-based matched cohort study in Korea': reply from authors.
    Br J Dermatol. 2020 Aug 7. doi: 10.1111/bjd.19465.
    PubMed         Abstract available


    Cancer

  4. KASHANI-SABET M, Miller JR 3rd, Lo S, Nosrati M, et al
    Reappraisal of the prognostic significance of mitotic rate supports its reincorporation into the melanoma staging system.
    Cancer. 2020 Aug 11. doi: 10.1002/cncr.33088.
    PubMed         Abstract available


    Cancer Lett

  5. JEONG Y, Kim GB, Ji Y, Kwak GJ, et al
    Dendritic cell activation by an E. coli-derived monophosphoryl lipid A enhances the efficacy of PD-1 blockade.
    Cancer Lett. 2020;472:19-28.
    PubMed         Abstract available


    Int J Cancer

  6. MENGONI M, Braun AD, Gaffal E, Tuting T, et al
    The aryl hydrocarbon receptor promotes inflammation-induced dedifferentiation and systemic metastatic spread of melanoma cells.
    Int J Cancer. 2020 Aug 13. doi: 10.1002/ijc.33252.
    PubMed         Abstract available


    J Am Acad Dermatol

  7. CROLEY JA, Joseph AK, Wagner RF Jr
    Discrepancies in the Mohs Micrographic Surgery appropriate use criteria.
    J Am Acad Dermatol. 2020;82:e55.
    PubMed        

  8. KRISTENSEN KB, Pedersen SA, Schmidt SAJ, Pottegard A, et al
    Use of antiepileptic drugs and risk of skin cancer: A nationwide case-control study.
    J Am Acad Dermatol. 2020;82:326-335.
    PubMed         Abstract available

  9. CHAN L, Hwang SJE, Byth K, Kyaw M, et al
    Survival and prognosis of individuals receiving programmed cell death 1 inhibitor with and without immunologic cutaneous adverse events.
    J Am Acad Dermatol. 2020;82:311-316.
    PubMed         Abstract available

  10. HEYMANN WR
    Juvenile lichen sclerosus: A loss of innocence.
    J Am Acad Dermatol. 2020;82:301-302.
    PubMed        

  11. BURNETT ME, Brodland DG, Zitelli JA
    Long-term outcomes of Mohs micrographic surgery for invasive melanoma of the trunk and proximal extremities.
    J Am Acad Dermatol. 2020 Aug 4. pii: S0190-9622(20)32316.
    PubMed         Abstract available

  12. CUEVAS RG, Villani A, Apalla Z, Kyrgidis A, et al
    Dermatoscopic predictors of melanoma arising in small- and medium-sized congenital nevi.
    J Am Acad Dermatol. 2020 Aug 4. pii: S0190-9622(20)32348.
    PubMed        

  13. CORTEZ JL, Vasquez J, Wei ML
    The Impact of Demographics, Socioeconomics, and Healthcare Access on Melanoma Outcomes.
    J Am Acad Dermatol. 2020 Aug 9. pii: S0190-9622(20)32405.
    PubMed         Abstract available


    J Immunol

  14. BALLY APR, Neeld DK, Lu P, Majumder P, et al
    PD-1 Expression during Acute Infection Is Repressed through an LSD1-Blimp-1 Axis.
    J Immunol. 2020;204:449-458.
    PubMed         Abstract available


    J Invest Dermatol

  15. SWAMINATHAN K, Campbell A, Papalazarou V, Jaber-Hijazi F, et al
    The RAC1 target NCKAP1 plays a crucial role in progression of BRAF/PTEN -driven melanoma in mice.
    J Invest Dermatol. 2020 Aug 7. pii: S0022-202X(20)31956.
    PubMed         Abstract available


    J Surg Oncol

  16. STAHLIE EHA, van der Hiel B, Stokkel MPM, Schrage YM, et al
    The use of FDG-PET/CT to detect early recurrence after resection of high-risk stage III melanoma.
    J Surg Oncol. 2020 Aug 11. doi: 10.1002/jso.26155.
    PubMed         Abstract available

  17. NEMIR S, Mericli AF, Adelman DM, Liu J, et al
    A reconstructive algorithm of oncologic defects of the upper trunk and shoulder girdle: Factors predicting complexity and outcomes.
    J Surg Oncol. 2020;122:283-292.
    PubMed         Abstract available


    Melanoma Res

  18. SAMARAN Q, Belakebi D, Theret S, Becquart O, et al
    Hemophagocytic lymphohistiocytosis in advanced melanoma treated with dabrafenib and trametinib combination: two cases.
    Melanoma Res. 2020 Aug 7. doi: 10.1097/CMR.0000000000000690.
    PubMed         Abstract available


    PLoS One

  19. CHENG Y, Huang Z, Liao Q, Yu X, et al
    Risk of second primary breast cancer among cancer survivors: Implications for prevention and screening practice.
    PLoS One. 2020;15:e0232800.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: